• Info
  • Insider Ownership

Insider Trading & Ownership of Robert A. Lenz

Location
Watertown, MA
Summary
The estimated net worth of Robert A. Lenz is at least $516,616 dollars as of 18 Mar 2026. Robert A. Lenz is the Head of R&D of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $516.6K.
Signature
/s/ Xi-Yong (Sean) Fu as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Robert A. Lenz and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Robert A. Lenz has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $516,616.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Neumora Therapeutics, Inc. ($516,616).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Robert A. Lenz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. Head of R&D $516,616 18 Feb 2025
LBRX LB PHARMACEUTICALS INC Director 06 Mar 2026
NBP NovaBridge Biosciences Director 18 Mar 2026

Insider Transactions Reported by Robert A. Lenz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored